journal
https://read.qxmd.com/read/36464992/correction-to-adjuvant-pd-1-inhibitor-versus-high-dose-interferon-%C3%AE-2b-for-chinese-patients-with-cutaneous-and-acral-melanoma-a-retrospective-cohort-analysis
#1
(no author information available yet)
No abstract text is available yet for this article.
December 5, 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346210/high-versus-low-dose-oral-isotretinoin-in-the-treatment-of-cutaneous-and-genital-warts
#2
RANDOMIZED CONTROLLED TRIAL
Ahmad Nofal, Mohamed M Fawzy, Fatma Eldeeb, Hager Nofal, Esraa E El-Hawary
Although oral isotretinoin has been considered as a potential therapeutic option for the treatment of different types of warts, the optimum dosage regimen is not yet well-established. To evaluate the efficacy and adverse effects of high versus low doses of oral isotretinoin in the treatment of cutaneous and genital warts. The study included 100 patients who were randomly assigned to two groups, 50 patients in each. Group 1 received 0.6 mg/kg/day (high dose isotretinoin) and Group 2 received 0.3 mg/kg/day (low dose isotretinoin)...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346039/evaluation-of-the-efficacy-and-relapse-rates-of-treatment-protocols-for-moderate-acne-using-isotretinoin-based-on-the-global-acne-grading-system-randomized-controlled-comparative-study
#3
JOURNAL ARTICLE
Bushra Kassem, Mohammad Ismail, Fouz Hassan
Protocols for treating acne with isotretinoin have varied widely because some factors associated with relapse and treatment duration have not yet been fully determined. This paper evaluates the effectiveness of conventional, low, and intermittent isotretinoin dosage protocols in the treatment of moderate acne and investigates the relationships between GAGS score, treatment duration and relapse rate. The 107 patients with moderate acne were randomly divided into three groups who received isotretinoin for 24 weeks (Group A: 0...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346030/simvastatin-and-non-segmental-vitiligo-a-new-potential-treatment-option
#4
JOURNAL ARTICLE
Engi Seif E Shaker, Sherihan H Allam, Maaly M Mabrouk, Nashwa M Elgharbawy, Shady Fikry Abdel Salaam
There is a paucity of data about the impact of systemic statins on vitiliginous lesions in non-segmental vitiligo (NSV) patients. To the best of our knowledge, no other studies have considered the correlation between lipid disturbances in vitiligo and vitiligo disease activity (VIDA) score. We sought in this study to evaluate the influence of simvastatin on vitiliginous lesions in NSV patients with dyslipidemia and study the correlation between VIDA score and lipid profile. This clinical trial started with 120 patients with NSV, 79 patients had dyslipidemia and received simvastatin 80 mg daily (till normalization of lipid profile or for 4 months, which came first) and only 63 patients continued till the end of the study...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346028/comparison-of-1064-nm-q-switched-nd-yag-laser-and-jessner-peeling-in-melasma-treatment
#5
JOURNAL ARTICLE
Ilgen Ertam Sagduyu, Onur Marakli, Gokturk Oraloglu, Ecem Bulut Okut, Idil Unal
Melasma is an acquired hyperpigmentation disease characterized by hyperpigmented patches in sun-exposed areas that significantly impairs life quality. Topical treatments such as hydroquinone, retinoic acid, azelaic acid, chemical peels and laser treatments are among the main treatment options. In our study, we aimed to compare the effectiveness of Jessner peeling and 1064 nm Q-switched Nd:YAG laser in melasma treatment. For this purpose, Jessner peeling was applied to 20 patients and 1064 nm Q-switched Nd: YAG laser was applied to 19 patients of 39 melasma patients who applied to the cosmetology unit of Ege University department of dermatology and venereal diseases between November 2018-March 2020...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346027/comprehensive-treatment-of-basal-cell-carcinoma-in-nevoid-basal-cell-carcinoma-syndrome-with-5-fluorouracil-and-salicylic-acid
#6
LETTER
Yangyiyi Yu, Guiying Zhang, Siqi Fu
No abstract text is available yet for this article.
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346024/cutaneous-lupus-erythematosus-variants-responsive-to-janus-kinase-inhibition
#7
LETTER
Lokapriya Ananthan, Megan Williams, Huw Morgan, Girish K Patel
No abstract text is available yet for this article.
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36336954/melanoma-surgery-an-update
#8
REVIEW
Uwe Wollina
Cutaneous melanoma is the major cause of mortality from all skin cancers. The treatment has been revolutionized in recent years by introduction of immunotherapy and targeted therapy for melanoma patients Stages III and IV. Therefore, the role of surgery in melanoma treatment needs to be redefined. In this narrative review, we will focus on surgery for diagnosis, treatment of primary tumor, and metastases in the era of new and effective medical treatment options. Neoadjuvant therapy is currently investigated in several trials...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36321647/investigating-the-efficacy-and-safety-of-calcipotriol-betamethasone-dipropionate-foam-and-laser-microporation-for-psoriatic-nail-disease-a-hybrid-trial-using-a-smartphone-application-optical-coherence-tomography-and-patient-reported-outcome-measures
#9
RANDOMIZED CONTROLLED TRIAL
Vinzent Kevin Ortner, Victor Desmond Mandel, Kresten Skak, John Robert Zibert, Mélanie Bourlioux, Christoffer Valdemar Nissen, Christine Sofie Krohn Fuchs, Peter Alshede Philipsen, Merete Haedersdal
There is a lack of efficacious topical treatments for patients suffering from psoriatic nail disease (PND). We investigated the efficacy of Calcipotriol-Betamethasone Dipropionate (Cal/BD) foam with and without ablative fractional laser (AFL) in patients with PND. A total of 144 nails from 11 patients were treated in a 24-week long, open-label, randomized, intra-patient controlled proof-of-concept hybrid trial. In addition to daily Cal/BD foam application, half of each patient's psoriatic nails were randomized to receive optical coherence tomography (OCT)-guided AFL treatment at baseline, 6-, and 12-week follow-ups...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36279306/real-world-experience-of-secukinumab-in-moderate-to-severe-psoriasis-patients-in-thailand-characteristics-effectiveness-and-safety
#10
JOURNAL ARTICLE
Pravit Asawanonda, Bensachee Pattamadilok, Leena Chularojanamontri, Mati Chuamanochan, Charoen Choonhakarn, Panlop Chakkavittumrong, Naruemon Sangob, Natta Rajatanavin
Secukinumab demonstrated high efficacy and favorable safety profile in patients with moderate-to-severe plaque psoriasis (PsO) in clinical trials. However, understanding of patient characteristics and clinical outcomes in real world in Thailand is still limited. To describe patient characteristics, effectiveness and safety of secukinumab in Thai PsO patients. This retrospective study analyzed data from medical records of adult PsO patients who initiated secukinumab at 7 dermatology centers from September 2017 to April 2021...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36269309/a-case-of-atopic-dermatitis-associated-dupilumab-resistant-alopecia-totalis-successfully-treated-with-baricitinib
#11
LETTER
Takashi Seo, Kentaro Izumi, Takuya Kawamura, Masumi Tsujiwaki, Hideyuki Ujiie
No abstract text is available yet for this article.
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36259229/fatal-low-dose-methotrexate-toxicity-a-case-report-and-literature-review
#12
REVIEW
Samantha Ouellette, Rohan Shah, Shazli Razi, Gina Ashforth, Cindy Wassef
Methotrexate (MTX) is a chemotherapeutic agent that acts primarily by inhibiting the folic acid cycle. In addition to its application for treating malignancies, MTX is also used to treat chronic inflammatory diseases including psoriasis. Adverse effects have been reported even at low doses (up to 25 mg/week), and there is risk of toxicity in the form of myelosuppression, hepatotoxicity, or pulmonary fibrosis. Here, we report a case of a 67-year-old male with a past medical history of end stage renal disease on peritoneal dialysis and moderate-to-severe psoriasis with psoriatic arthritis presented with abdominal pain, diarrhea, rash, mucositis, and mucocutaneous ulcers and erosions...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36226669/tapinarof-for-the-treatment-of-psoriasis
#13
REVIEW
Sofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, Tiago Torres
Although topical drugs are the mainstay of treatment for patients with mild-to-moderate psoriasis, the developments observed in this field in the last two decades have been limited. The most commonly used drugs are still vitamin D analogues and corticosteroids, both with several limitations. The aryl hydrocarbon receptor (AhR) plays a role in the pathogenesis of psoriasis, and tapinarof, a novel, first-in-class, small molecule topical therapeutic AhR-modulating agent has been recently approved by the FDA for the topical treatment of plaque psoriasis in adults...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36222320/comparison-between-chronic-spontaneous-urticaria-and-chronic-induced-urticaria-on-the-efficacy-of-omalizumab-treatment-a-systematic-review-and-meta-analysis
#14
REVIEW
Zhu-Han He, Shuo-Cheng Qiu, Zhi-Wei Huang, Guo-Qiang Zhang, Qing-Qing An, Feng Qu, Na Wang
This meta-analysis aimed to assess the efficacy of omalizumab in the treatment of refractory-to-antihistamines chronic induced urticaria (CIndU) in comparison with that of refractory-to-antihistamines chronic spontaneous urticaria (CSU). We retrieved interventional studies and observational studies on omalizumab efficacy to CIndU patients and efficacy comparison between CSU and CIndU both refractory to H1-antihistamines in electronic databases (accessed till May 2022). The odd ratio (OR) and 95% confidence interval (CI) was calculated with a random-effect model in this meta-analysis...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219538/dupilumab-advances-in-the-off-label-usage-of-il4-il13-antagonist-in-dermatoses
#15
REVIEW
Fengming Jia, Qing Zhao, Peidian Shi, Hong Liu, Furen Zhang
Type 2 immune response refers to a complicated series of immune responses characterized by Th2 polarization and Th2 cytokines secretion. The IgE secretion, airway hypersensitivity, and effector cell recruitment (eosinophils, mast cells, basophils) in skin lesion and peripheral blood stream could be upregulated during the activation of type 2 immune response. Th1/Th2 ratio, also referred as Th1/Th2 balance, represent the T lymphocytes immune pattern to a certain degree: Th1-dominated responses are often involved in intracellular infections (e...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219536/rapid-response-of-recalcitrant-linear-iga-bullous-dermatosis-to-omalizumab-a-case-report-and-literature-review
#16
REVIEW
Xin Tong, Long Geng, Xing-Hua Gao, Hong-Hui Xu
No abstract text is available yet for this article.
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219526/atypical-presentation-of-sweet-syndrome-with-nodular-erythema-and-oral-ulcerations-provoked-by-ad26-cov2-s-sars-cov-2-vaccination-and-review-of-literature
#17
REVIEW
Agata Bechtold, Agnieszka Owczarczyk-Saczonek
The aim of this article is to present the case of acute febrile neutrophilic dermatosis (Sweet syndrome-SS) after Ad26.COV2.S vaccination against SARS-CoV-2. To the best of our knowledge, this is the second case of SS provoked by this specific vaccine. What is more, the mildly symptomatic beginning of the disease, later followed by typical SS manifestation with a variety of symptoms including nodular erythema of the feet and oral ulcerations, made it very challenging to establish the diagnosis. The article focuses on the current literature on the acute febrile neutrophilic dermatosis, along with the coexistence with other neutrophilic dermatoses and anti-SARS-CoV-2 vaccinations as provoking factors...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219518/which-is-more-effective-in-atrophic-acne-scars-treatment-microneedling-alone-or-platelet-rich-plasma-alone-or-combined-both-therapeutic-modalities
#18
RANDOMIZED CONTROLLED TRIAL
Sahar A Ismail, Nanis A H Khella, Doaa A E Abou-Taleb
Acne scarring usually causes cosmetic and psychological problems. Our aim of the study was to compare the efficacy of microneedling alone, intradermal injection of platelet rich plasma (PRP) alone and combined microneedling with PRP in the treatment of atrophic post-acne scars. Thirty adult patients with facial post-acne scars were randomly recruited and divided into two groups: A and B. Group A: included 15 patients; the left sides of their faces were treated with microneedling by dermapen followed by PRP while on the right side of the faces microneedling alone was performed...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36214268/topical-cyclosporine-hydrogel-preparation-a-new-therapeutic-option-in-the-treatment-of-nail-psoriasis
#19
JOURNAL ARTICLE
Giuseppe Gallo, Luca Mastorino, Diego Barilà, Francesco Cattel, Michele Panzone, Pietro Quaglino, Simone Ribero, Paolo Dapavo
Nail psoriasis is a chronic nail disorder that commonly affects psoriatic patients causing severe distress despite the limited body surface area. Treatments for nail psoriasis are limited, as nails are often difficult to treat with topical therapies, and among different systemic agents responses are unpredictable. We carried out a prospective study in order to analyze the effectiveness and tolerability of topical cyclosporine hydrogel ointment in nail psoriasis. Three patients, for a total of 44 nails, were treated with topical cyclosporine hydrogel ointment...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36200594/children-atopic-dermatitis-diagnosis-mimics-overlaps-and-therapeutic-implication
#20
REVIEW
Maddalena Napolitano, Gabriella Fabbrocini, Fabrizio Martora, Lucia Genco, Matteo Noto, Cataldo Patruno
Atopic dermatitis (AD) is a chronic inflammatory, itching skin with a significant psychosocial impact on patients and relatives. In adults and adolescents besides flexural eczema, head and neck eczema, and hand eczema, which are the most frequent clinical phenotypes (84.9% and 84.2%, respectively), there are also other possible presentation such as, portrait-like dermatitis (20.1%), diffuse eczema (6.5%), eczema nummulare-like (5.8%), prurigo nodularis-like (2.1%) and erythrodermia (0.7%). Diagnosis can be easy due to the typically distributed eczematous lesions, albeit with age-related differences, However, it is also extremely heterogeneous in severity, course, and sometimes particular clinical features...
December 2022: Dermatologic Therapy
journal
journal
32674
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.